These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35001739)

  • 1. Circ_0003645 serves as miR-335-5p sponge to promote the biological process of diffuse large B-cell lymphoma by upregulating NFIB.
    Lin D; Wang Y; Lei L; Lin C
    Autoimmunity; 2022 Mar; 55(2):127-135. PubMed ID: 35001739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircRNA_OTUD7A upregulates FOXP1 expression to facilitate the progression of diffuse large B-cell lymphoma via acting as a sponge of miR-431-5p.
    Liu W; Lei L; Liu X; Ye S
    Genes Genomics; 2021 Jun; 43(6):653-667. PubMed ID: 33830472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ_0069718 promotes the progression of breast cancer by up-regulating NFIB through sequestering miR-590-5p.
    Zhao Y; Ma X; Shi W
    Mamm Genome; 2021 Dec; 32(6):517-529. PubMed ID: 34632534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sevoflurane inhibits the malignant phenotypes of glioma through regulating miR-146b-5p/NFIB axis.
    Wang H; Cheng G; Quan L; Qu H; Yang A; Ye J; Feng Y; Li X; Shi X; Pan H
    Metab Brain Dis; 2022 Jun; 37(5):1373-1386. PubMed ID: 35386035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ_0007841 knockdown confers cisplatin sensitivity to ovarian cancer cells by down-regulation of NFIB expression in a miR-532-5p-dependent manner.
    Gao Y; Huang Y
    J Chemother; 2023 Apr; 35(2):117-130. PubMed ID: 35380509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of circ-PIP5K1A overcomes resistance to cisplatin in ovarian cancer by miR-942-5p/NFIB axis.
    Sheng H; Wang X
    Anticancer Drugs; 2023 Feb; 34(2):214-226. PubMed ID: 36730637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA PCAT1 enhances cell proliferation, migration and invasion by miR-508-3p/NFIB axis in diffuse large B-cell lymphoma.
    Tian M; Li Y; Zheng W; Liu QQ; Zhang XL; Liu JL; Zhang S; Sheng YX; Fan CB; Zhang WL
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2567-2576. PubMed ID: 33829443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circ_0074027 Contributes to Non-Small Cell Lung Cancer Progression by Upregulating
    Yu C; Ying J; Yu K; Shen W; Jiang M
    Cancer Biother Radiopharm; 2022 Mar; 37(2):73-83. PubMed ID: 32580576
    [No Abstract]   [Full Text] [Related]  

  • 9. Hsa_circ_0000877 facilitates the progression of diffuse large B-cell lymphoma by miR-370-3p/mitogen-activated protein kinase kinase kinase kinase 4/Hippo pathway.
    Zhan C; Zhou H; Zhang W; Si C
    Anticancer Drugs; 2022 Nov; 33(10):1091-1102. PubMed ID: 36066383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA circ-LARP1B contributes to cutaneous squamous cell carcinoma progression by targeting microRNA-515-5p/TPX2 microtubule nucleation factor axis.
    Wang L; Hou S; Li J; Tian T; Hu R; Yu N
    Bioengineered; 2022 Jan; 13(1):1209-1223. PubMed ID: 34982022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_0011058 facilitates proliferation, angiogenesis and radioresistance in papillary thyroid cancer cells by positively regulating YAP1 via acting as miR-335-5p sponge.
    Zhang Z; Wang W; Su Z; Zhang J; Cao H
    Cell Signal; 2021 Dec; 88():110155. PubMed ID: 34562605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA circ-FAM158A promotes retinoblastoma progression by regulating miR-138-5p/SLC7A5 axis.
    Zheng T; Chen W; Wang X; Cai W; Wu F; Lin C
    Exp Eye Res; 2021 Oct; 211():108650. PubMed ID: 34102206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsa_circ_0000231 knockdown inhibits the glycolysis and progression of colorectal cancer cells by regulating miR-502-5p/MYO6 axis.
    Liu Y; Li H; Ye X; Ji A; Fu X; Wu H; Zeng X
    World J Surg Oncol; 2020 Sep; 18(1):255. PubMed ID: 32993655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
    Zang H; Li Y; Zhang X; Huang G
    Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
    Zhu X; Du J; Gu Z
    Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA circ_0008360 Inhibits the Proliferation, Migration, and Inflammation and Promotes Apoptosis of Fibroblast-Like Synoviocytes by Regulating miR-135b-5p/HDAC4 Axis in Rheumatoid Arthritis.
    Hao J; Chen Y; Yu Y
    Inflammation; 2022 Feb; 45(1):196-211. PubMed ID: 34462830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_0027599 elevates RUNX1 expression via sponging miR-21-5p on gastric cancer progression.
    Han J; Yang Z; Zhao S; Zheng L; Tian Y; Lv Y
    Eur J Clin Invest; 2021 Nov; 51(11):e13592. PubMed ID: 34032284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis.
    Ding Z; Guo L; Deng Z; Li P
    Ann Hepatol; 2020; 19(3):269-279. PubMed ID: 32089501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circ_0029589 regulates proliferation, migration, invasion, and apoptosis in ox-LDL-stimulated VSMCs by regulating miR-424-5p/IGF2 axis.
    Yu H; Zhao L; Zhao Y; Fei J; Zhang W
    Vascul Pharmacol; 2020 Dec; 135():106782. PubMed ID: 32860985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_0082182 upregulates the NFIB level via sponging miR-326 to promote oxaliplatin resistance and malignant progression of colorectal cancer cells.
    Wang Z; Liu J; Yang T; Wang Q; Liang R; Tang J
    Mol Cell Biochem; 2023 May; 478(5):1045-1057. PubMed ID: 36219357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.